Par installs Pera as commercial head

Share this article:

Par Pharmaceuticals named Antonio Pera as chief commercial officer. Pera previously worked as SVP, commercial operations, JHP Pharmaceuticals, which was acquired by Par at the end of January. In his new role, Pera will manage the organization's relationships with major trade partners.

Pera also worked at AmeriSourceBergen as SVP, supply chain management.

"He has a demonstrated expertise in the marketing, sales and distribution of generic drugs," stated Paul Campanelli, CEO of Par, adding, “We look forward to the leadership Tony will provide our commercial organization and the many contributions he will make to our company."

Share this article:
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

Researchers hit links for charity

The PMR Charities Golf Classic teed up more than $20,000 for St. Jude Children's Research Hospital.

FDA to review Neupogen biosimilar

Novartis subsidiary Sandoz announced Thursday that the FDA has agreed to review its filgrastim biosimilar which is already approved in 40 countries.

FDA approves a new painkiller

Targiniq ER combines the prescription opioid oxycodone and naloxone, which is often used to treat overdoses.